CF3CH2OBu | 80054-66-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: CF3CH2OBu
• 英文别名: Butyl(2,2,2-trifluoroethyl) ether；1-(2,2,2-trifluoroethoxy)butane
• CAS: 80054-66-6
• 化学式: C₆H₁₁F₃O
• 分子量: 156.148
• InChiKey: OSUASOUSEXWOQS-UHFFFAOYSA-N

物化性质

• 沸点：
  100.8±35.0 °C(Predicted)
• 密度：
  1.038±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  10
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  2-重氮基-1,1,1-三氟乙烷 、 正丁醇 在 tetrafluoroboric acid 作用下， 以 氘代氯仿 为溶剂， 以97%的产率得到CF3CH2OBu
  参考文献：
  名称：

  Acid-catalyzed reactions of 2,2,2-trifluorodiazoethane for analysis of functional groups by fluorine-19 nuclear magnetic resonance spectrometry

  摘要：

  DOI：

  10.1021/ac00240a040
• 作为试剂：
  描述：

  苯硒酚 在 双氧水 、 CF3CH2OBu 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 9.0h， 生成 [Difluoro(phenylselanyl)methyl] acetate
  参考文献：
  名称：

  Reaction of Difluoromethyl Phenyl Selenoxide with Acetic Anhydride. A Route to Difluoro(phenylseleno)methylation of Ethers

  摘要：

  Difluoromethyl phenyl selenoxide (2) has been prepared and allowed to react with acetic anhydride in the presence of cyclic ethers and sulfides. Difluorophenylselenomethylation occurred smoothly on reacting 2 with Ac2O in refluxing dichloromethane to give omega-[difluoro(phenylseleno)methoxy]alkyl acetates 4 in 34-87% yields. A sequential reaction of Pummerer type rearrangement, difluorocarbene formation, electrophilic addition of the carbene to oxygen of ethers leading to oxonium ylide, and trapping with phenylselenenyl acetate is proposed.

  DOI：

  10.1021/jo00107a016

文献信息

• Expedient and efficient one pot synthesis of trifluoroethyl ethers from metal free 2,4,6-tris-(2,2,2-trifluoro-ethoxy)-[1,3,5] triazene
  作者：Shrawan Kumar Mangawa、Chiranjeev Sharma、Ashawani kumar Singh、Satish K. Awasthi

  DOI：10.1039/c5ra00618j

  日期：——

  An efficient synthesis of fluorinated alkyl and aryl ethers was achieved by the use of s-triazene derived fluorinated reagent 2,4,6-tris-(2,2,2-trifluoro-ethoxy)-[1,3,5] triazene (TriTFET).

  通过使用由s-三氮烯衍生的氟化试剂2,4,6-三(2,2,2-三氟乙氧基)-[1,3,5] 三氮烯(TriTFET)，实现了氟代烷基和芳基醚的高效合成。
• Pyrrolopyridazinone Compound
  申请人：Hagihara Masahiko

  公开号：US20090036453A1

  公开（公告）日：2009-02-05

  The present invention discloses a pyrrolopyridazinone compound represented by the formula (1): wherein R 1 represents C 1 -C 2 alkyl group or halogeno C 1 -C 2 alkyl group, R 2 repersents C 3 -C 5 cycloalkyl group, (C 3 -C 5 cycloalkyl)C 1 -C 2 alkyl group or C 1 -C 3 alkyl group, R 3 represents hydrogen atom, or methylene group or cis-vinylene group for forming substituted oxygen-containing hetero ring in combination with group —O—R 2 , R 4 represents hydrogen atom, halogen atom, C 1 -C 8 alkyl group, C 2 -C 6 alkenyl group, C 2 -C 6 alkynyl group, hydroxy C 3 -C 6 alkenyl group, hydroxy C 3 -C 6 alkynyl group, C 1 -C 6 alkyl group substituted by substituent(s) selected from Substituent group (a), C 3 -C 6 cycloalkyl group which may be substituted by substituent(s) selected from Substituent group (b), “C 1 -C 3 alkyl group which is substituted by C 3 -C 6 cycloalkyl group which may be substituted by substituent(s) selected from Substituent group (b), and which may be substituted by a hydroxy group”, an aromatic ring group or heteroaromatic ring group each of which may be substituted by a substituent(s) selected from Substituent group (c) or “C 1 -C 2 alkyl group which is substituted by aromatic ring group or heteroaromatic ring group each of which may be substituted by group(s) selected from Substituent group (c), and which may be substituted by a hydroxy group”, Substituent group (a) represents a halogen atom, hydroxy group, cyano group, carboxy group, C 1 -C 5 alkoxy group, halogeno C 1 -C 4 alkoxy group, C 3 -C 6 cycloalkoxy group, (C 3 -C 6 cycloalkyl)C 1 -C 2 alkoxy group, C 1 -C 4 alkoxycarbonyl group, C 2 -C 4 alkanoyl group, C 2 -C 4 alkanoyloxy group or C 1 -C 4 alkyl-substituted amino group, Substituent group (b) represents a hydroxy group or a halogen atom, Substituent group (c) represents a halogen atom, a hydroxy group, a cyano group, a nitro group, a carboxy group, C 1 -C 5 alkoxy group, C 1 -C 4 alkoxycarbonyl group, C 2 -C 4 alkanoyloxy group, C 1 -C 4 alkyl-substituted amino group or a C 1 -C 4 alkyl group which may be substituted by a substituent(s) selected from the group consisting of (a halogen atom, a hydroxy group and a carboxy group), or a pharmaceutically acceptable salt thereof.

  本发明公开了一种由式（1）表示的吡咯吡啶二酮化合物：其中，R1代表C1-C2烷基或卤代C1-C2烷基，R2代表C3-C5环烷基、（C3-C5环烷基）C1-C2烷基或C1-C3烷基，R3代表氢原子，或与基团-O-R2结合形成取代含氧杂环的亚甲基或顺式乙烯基，R4代表氢原子、卤素原子、C1-C8烷基、C2-C6烯基、C2-C6炔基、羟基C3-C6烯基、羟基C3-C6炔基、由从取代基团（a）中选择的取代基团取代的C1-C6烷基，可由从取代基团（b）中选择的取代基团取代的C3-C6环烷基，可由从取代基团（b）中选择的取代基团取代的C1-C3烷基，且可由羟基取代，芳香环基或杂芳香环基，每个都可由从取代基团（c）中选择的取代基团取代或由取代基团（c）选择的基团取代的C1-C2烷基，且可由羟基取代，取代基团（a）表示卤素原子、羟基、氰基、羧基、C1-C5烷氧基、卤代C1-C4烷氧基、C3-C6环烷氧基、（C3-C6环烷基）C1-C2烷氧基、C1-C4烷氧羰基、C2-C4酰基、C2-C4酰氧基或C1-C4烷基取代的氨基基团，取代基团（b）表示羟基或卤素原子，取代基团（c）表示卤素原子、羟基、氰基、硝基、羧基、C1-C5烷氧基、C1-C4烷氧羰基、C2-C4酰氧基、C1-C4烷基取代的氨基基团或可由从由卤素原子、羟基和羧基组成的基团中选择的取代基团取代的C1-C4烷基，或其药学上可接受的盐。
• DIAZACARBAZOLES AND METHODS OF USE
  申请人：Chen Huifen

  公开号：US20110124654A1

  公开（公告）日：2011-05-26

  The invention relates to 1,5-diazacarbazole compounds of Formula (I), (I-a), (I-b), (I-c), (I-d), (I-e), (I-f), (I-g) and (I-h) which are useful as kinase inhibitors, more specifically useful as checkpoint kinase 1 (chk1) inhibitors, thus useful as cancer therapeutics. The invention also relates to compositions, more specifically pharmaceutical compositions comprising these compounds and methods of using the same to treat various forms of cancer and hyperproliferative disorders, as well as methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.

  本发明涉及一种1,5-二氮杂咔唑化合物，其化学式为(I)、(I-a)、(I-b)、(I-c)、(I-d)、(I-e)、(I-f)、(I-g)和(I-h)，它们可用作激酶抑制剂，更具体地可用作检查点激酶1（chk1）抑制剂，因此可用作癌症治疗药物。本发明还涉及包含这些化合物的组合物，更具体地是包含这些化合物的制药组合物，以及使用这些化合物治疗各种癌症和高增殖性疾病的方法，以及使用这些化合物进行哺乳动物细胞的体外、原位和体内诊断或治疗，或相关病理条件的方法。
• OLEFIN OLIGOMERIZATION CATALYST AND PROCESS FOR THE PREPARATION OF OLEFIN OLIGOMER USING IT
  申请人：NIPPON OIL COMPANY, LTD.

  公开号：EP0758563A1

  公开（公告）日：1997-02-19

  An oligomerization catalyst according to the invention comprises a nickel compound (A); an organophosphoric compound (B); an organoaluminum compound (C); and a compound of the group consisting of carbon-halogen bond-containing compounds, oxoacid and salts thereof, sulfonic acid and derivatives thereof, and compounds of any of the formulae QX4n, QRn, QR'n, QX4lRm, QX4lR'm, QRlR'm, Q1(BR4)p and R''(BR4) wherein Q is an element of the group consisting of Mg, Ti, Zr, B and Sn, Q1 is an element of the group consisting of Li, Na, K, Ca and Zn, X4 is a halogen or hydrogen atom, R is a C1-C12 hydrocarbon group, R' is a C1-C12 oxygen-containing hydrocarbon groiup, R'' is a C1-C20 hydrocarbon group or an ammonium group, n is a valence of Q, l, m is a natural member that satisfied n=l+m, and p is a valence of Q1. This catalyst is useful for the production of alpha-olefinic oligomers.

  根据本发明的低聚催化剂包括镍化合物（A）；有机磷化合物（B）；有机铝化合物（C）；以及由以下物质组成的一组化合物：含碳-卤素键化合物、氧酸及其盐、磺酸及其衍生物，以及式 QX4n、QRn、QR'n、QX4lRm、QX4lR'm、QRlR'm、Q1(BR4)p 和 R''(BR4)中任何一种的化合物 其中 Q 是由镁、钛、锆、硼和锡组成的组中的元素、X4 是卤素或氢原子，R 是 C1-C12 烃基，R'是 C1-C12 含氧烃基，R''是 C1-C20 烃基或铵基，n 是 Q 的化合价，l、m 是满足 n=l+m 的自然数，p 是 Q1 的化合价。这种催化剂可用于生产α-烯烃低聚物。
• Quinazoline derivative, preparation method therefor, and pharmaceutical composition and application thereof
  申请人：ARROMAX PHARMATECH CO., LTD.

  公开号：US10196365B2

  公开（公告）日：2019-02-05

  Disclosed are a quinazoline derivative, a preparation method therefor, and a pharmaceutical composition and an application thereof. The present invention provides a compound represented by general formula I, a stereoisomer thereof and a pharmaceutical acceptable salt or a solvate thereof. The quinazoline derivative of the present invention has a unique chemical structure, is characterized by irreversibly inhibiting EGFR tyrosine kinase, has high biological activity, apparently improves the inhibiting effect on the EGFR tyrosine kinase, has quite strong tumor inhibiting effect on tumor cells and a transplantation tumor pathological model of animal tumors, and has good market developing prospects.

  本发明公开了一种喹唑啉衍生物、其制备方法、药物组合物及其应用。本发明提供了一种通式 I 所代表的化合物、其立体异构体及其药用盐或溶液。本发明的喹唑啉衍生物具有独特的化学结构，以不可逆地抑制表皮生长因子受体酪氨酸激酶为特征，具有较高的生物活性，明显提高了对表皮生长因子受体酪氨酸激酶的抑制作用，对肿瘤细胞和移植瘤病理模型动物肿瘤具有相当强的抑瘤作用，具有良好的市场发展前景。